Keyword: Corden Pharma


CordenPharma & pHLIP Form RNA & Gene Delivery Alliance

08.01.2024 -

CordenPharma and pHLIP have announced their strategic alliance to collaborate in developing and commercializing the pHLIP-LNP targeted delivery platform for RNA-based and...


CordenPharma Completes Upgrade of US Peptide Production Site in Colorado

06.09.2023 -

CDMO CordenPharma, a specialist in active pharmaceutical ingredients (APIs), excipients, drug products and packaging services, inaugurated an increased commercial peptide...


CordenPharma Expands at US Site in Colorado

04.05.2023 -

CordenPharma is expanding strategically into synthetic oligonucleotide manufacturing at its plant at Boulder in the US state of Colorado. The two-phase investment is...


Wacker and CordenPharma in RNA Drugs Project

04.04.2023 -

Together with Munich’s Ludwig Maximilian University (LMU) and the Humboldt University of Berlin (HU Berlin), German companies Wacker Chemie and CordenPharma International...


CordenPharma Lifts xRNA Capability in Italy

13.06.2022 -

German CDMO CordenPharma, a specialist in Active Pharmaceutical Ingredients (APIs), excipients, drug products and packaging services (APIs), is investing more than €10...


Astorg to Acquire CordenPharma from ICIG

04.05.2022 -

Private equity investor Astorg has signed a binding agreement with International Chemical Investors Group (ICIG) to acquire Plankstadt, Germany-based CDMO CordenPharma...


CordenPharma Lifts Lipids Capacity in France

02.03.2022 -

Full-service CDMO CordenPharma is making a major investment to increase lipid manufacturing capacity at its CordenPharma Chenôve facility near Dijon, France. The project...


CordenPharma Sale Rumors Take Firm Shape

19.01.2022 -

Rumors that German pharmaceutical producer CordenPharma is up for sale have resurfaced following fresh reports that the company’s owner, International Chemical Investors...